Clinical Trial Update: Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.

View source ↗

Summary

Clinical trial update reporting completed study on dual therapy with raltegravir and darunavir/ritonavir in HIV-infected patients, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Integrase Inhibitors, HIV; HIV PROTEASE INHIB | Status: COMPLETED | Results posted: 2019-09-27